LIVE
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norway, France, the United States, Italy, Sweden, and. Track Blue Jet Healthcare Limited's live NSE:BLUEJET share price ₹638.00 (+2.10%), market cap ₹₹111B, P/E 44.7. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for BLUEJET — real-time NSE India stock intelligence.
Open
₹633.00
High
₹647.80
Low
₹623.00
Prev. Close
₹624.85
52W High
₹814.00
52W Low
₹325.00
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norway, France, the United States, Italy, Sweden, and
Key Takeaway
Blue Jet Healthcare Limited is rated buy with a P/E of 44.7x — understand the valuation context before sizing a position.
★ Recommended
Ask AI: Is Blue Jet Healthcare Limited fairly valued right now?
Because a P/E of 44.7x needs to be compared against sector peers and growth expectations to be meaningful.
Continue Research
View events affecting Blue Jet Healthcare Limited
Because the investment case must account for macro and company-specific developments — events reveal the 'why' behind price moves.
Trace sector ripple effects
Because Healthcare moves create upstream and downstream implications that affect the entire thesis.
Intelligence Path
Growth
Govt Exposure
Policy Dependence
Execution Quality
News Sensitivity
Debt Strength
235 Cr
Revenue
64 Cr
Net Profit
19.9%
ROE
0%
ROCE
14.28
EPS
| ₹ in Crore | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|
| Revenue | 721 | 710 | 1,030 | 947 | 1,122 |
| Net Profit | 160 | 164 | 305 | 248 | 305 |
| ROE (%) | — | — | — | 19.9% | 19.9% |
| EPS (₹) | — | — | — | 14.28 | 14.28 |
| Debt/Equity | — | — | — | 3.1 | 3.1 |